These findings suggest that the loss of KLK1 expression may promote inflammation‐related cancer transformation by activating the Bdkrb1+Adamdec1+ fibroblast subpopulation, which provides a new perspective on the potential mechanism of intestinal inflammation progression to cancer. Here, ADAMDEC1 is linked to cancer.